Food Preservative: A New Hope For Refractory Schizophrenia?
A study conducted by researchers of the China Medical University, Taiwan, has found that adding the common food preservative Sodium benzoate as an adjuvant to Clozapine, the "gold standard" treatment for patients with treatment-resistant schizophrenia improved the symptoms in patients with refractory schizophrenia.
The study involved 60 schizophrenia inpatients that had been stabilized with Clozapine. They were divided into three groups, and were treated for 6 weeks with the add-on therapy of 1 g/day sodium benzoate, 2 g/day sodium benzoate, or placebo.
According to the researchers, there was an improvement in the negative symptoms of schizophrenia in patients treated with Sodium benzoate compared to placebo. *The negative symptoms of schizophrenia comprise a range of deficits in communication, emotional responsiveness, socialization, and motivation (*Source: thebmj).
Moreover, the higher dose of Sodium benzoate produced better improvement than placebo in the ratings of the symptoms of schizophrenia, like PANSS-total score and PANSS-positive score, and quality of life.
Further studies are required to determine the optimal dose and treatment duration as well as the mechanisms of Sodium benzoate for Clozapine-resistant schizophrenia, say the researchers.
The study is published in Biological Psychiatry. (dpa)
Other news from the department science
Get the food & beverage industry in your inbox
From now on, don't miss a thing: Our newsletter for the food & beverage sector brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.